See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2020_Ionis_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 0.8467814163270807, 'aggregate_val': 1548565000, 'exp_sum': 838521000, 'exp_to_value': {'LiabilitiesCurrent': 273005000, 'LiabilitiesNoncurrent': 490060000, 'remainder_Liabilities': 75456000}} |
Graph
Absolute values for 0000874015, Ionis Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,720,597,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 25,674,000 |
| 2 | PropertyPlantAndEquipmentNet | 153,651,000 |
| 3 | remainder_Assets | 333,190,000 |
| 4 | LiabilitiesCurrent | 273,005,000 |
| 5 | LiabilitiesNoncurrent | 490,060,000 |
| 6 | remainder_Liabilities | 785,500,000 |
| 7 | CostOfGoodsAndServicesSold | 17,187,873 |
| 8 | SellingGeneralAndAdministrativeExpense | 356,709,424 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 354,310,748 |
| 11 | remainder_Revenues | 3,729,489,483 |
| 12 | remainder_NetIncome | 29,747,286 |
| 13 | remainder_ComprehensiveNetIncome | 18,629,533 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,233,112,000 |
| 1 | Liabilities | 1,548,565,000 |
| 2 | Expenses | 728,208,045 |
| 3 | Revenues | 3,729,489,483 |
| 4 | StockholdersEquity | 1,684,547,000 |
| 5 | NetIncome | 3,031,028,724 |
| 6 | ComprehensiveNetIncome | 3,040,343,490 |
| 7 | BaseVar | 4,643,875,674 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.81 |
| 9 | EconomicCapitalRatio | 3.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
